BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33352812)

  • 1. Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years.
    García-Velasco A; Zacarías-Pons L; Teixidor H; Valeros M; Liñan R; Carmona-Garcia MC; Puigdemont M; Carbajal W; Guardeño R; Malats N; Duell E; Marcos-Gragera R
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33352812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).
    Fuentes-Raspall R; Solans M; Roca-Barceló A; Vilardell L; Puigdemont M; Del Barco S; Comas R; García-Velasco A; Astudillo A; Carmona-Garcia MC; Marcos-Gragera R
    Cancer Epidemiol; 2017 Oct; 50(Pt A):1-8. PubMed ID: 28738268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain.
    Solans M; Fàbrega A; Morea D; Auñon-Sanz C; Granada I; Roncero JM; Blanco A; Kelleher N; Buch J; Saez M; Marcos-Gragera R
    Cancer Epidemiol; 2019 Feb; 58():8-11. PubMed ID: 30423540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study.
    Solans M; Serra L; Renart G; Osca-Gelis G; Comas R; Vilardell L; Gallardo D; Marcos-Gragera R
    Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S164-S169. PubMed ID: 28590273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.
    Alsina M; Marcos-Gragera R; Capdevila J; Buxó M; Ortiz RM; Barretina P; Vilardell L; Brunet J; Beltran M; Izquierdo Á
    Cancer Epidemiol; 2011 Dec; 35(6):e49-54. PubMed ID: 21840785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based survival of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain.
    Villavicencio A; Solans M; Auñon-Sanz C; Roncero JM; Marcos-Gragera R
    Cancer Epidemiol; 2020 Dec; 69():101841. PubMed ID: 33157510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival of central nervous system tumors in childhood and adolescence in Girona (Spain) 1990-2013: national and international comparisons.
    Rivas-Vilela S; Rubió-Casadevall J; Fàbrega-Ribas A; Joly-Torta C; Vilardell L; Marcos-Gragera R
    Clin Transl Oncol; 2019 Sep; 21(9):1177-1185. PubMed ID: 30712237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study.
    Rubió-Casadevall J; Puig-Vives M; Puigdemont M; Vilardell L; Carbó-Bagué A; Marcos-Gragera R; Vilar-Coromina N
    Clin Transl Oncol; 2018 Dec; 20(12):1617-1625. PubMed ID: 29873027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significantly reduced incidence and improved survival from prostate cancer over 25 years.
    Serdà-Ferrer BC; Sanvisens A; Fuentes-Raspall R; Puigdemont M; Farré X; Vidal-Vila A; Rispau-Pagès M; Baltasar-Bagué A; Marcos-Gragera R
    BMC Public Health; 2023 Dec; 23(1):2552. PubMed ID: 38129873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN).
    Pla C; Solans M; Ameijide A; Sanvisens A; Carulla M; Rojas MD; Alemán MA; Sáez-Lloret I; Díaz-Del-Campo C; Marcos-Navarro AI; Sainz-de-Aja L; Aizpurua-Atxega A; Lopez-de-Munain A; Sánchez MJ; Perucha J; Franch P; Chirlaque MD; Guevara M; Galceran J; Merino S; Marcos-Gragera R;
    Front Oncol; 2022; 12():1046307. PubMed ID: 36508554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.
    Sirri E; Castro FA; Kieschke J; Jansen L; Emrich K; Gondos A; Holleczek B; Katalinic A; Urbschat I; Vohmann C; Brenner H
    Pancreas; 2016 Jul; 45(6):908-14. PubMed ID: 26745860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007.
    Marcos-Gragera R; Galceran J; Martos C; de Munain AL; Vicente-Raneda M; Navarro C; Quirós-Garcia JR; Sánchez MJ; Ardanaz E; Ramos M; Mateos A; Salmerón D; Felipe S; Peris-Bonet R
    Clin Transl Oncol; 2017 Mar; 19(3):301-316. PubMed ID: 27447899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Solé F; Marcos-Gragera R
    Leuk Res; 2012 Oct; 36(10):1262-6. PubMed ID: 22784713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain.
    Rubió J; Marcos-Gragera R; Ortiz MR; Miró J; Vilardell L; Gironès J; Hernandez-Yagüe X; Codina-Cazador A; Bernadó L; Izquierdo A; Colomer R
    Eur J Cancer; 2007 Jan; 43(1):144-8. PubMed ID: 17055254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and age-standardized rates of pancreatic cancer in Sri Lanka from 2001 to 2010: An analysis of national cancer registry data.
    Jayarajah U; Almeida I; Fernando A; Seneviratne S; Samarasekera DN
    Indian J Cancer; 2021; 58(3):387-393. PubMed ID: 33402567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer epidemiology and survival in an Australian population.
    Luke C; Price T; Karapetis C; Singhal N; Roder D
    Asian Pac J Cancer Prev; 2009; 10(3):369-74. PubMed ID: 19640175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based study.
    Bouvier AM; Bossard N; Colonna M; Garcia-Velasco A; Carulla M; Manfredi S;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S63-S69. PubMed ID: 28005607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona.
    Camps-Vilaró A; Subirana I; Elosua R; Palomo I; Sanchis J; Tizón-Marcos H; Cainzos-Achirica M; Sala J; Masia R; Ramos R; Dégano IR; Marrugat J
    Rev Esp Cardiol (Engl Ed); 2024 Jun; 77(6):450-458. PubMed ID: 37981192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.